Tempus AI Inc. (TEM)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 82.89 |
Market Cap | 12.48B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -5.16 |
PE Ratio (ttm) | -15.87 |
Forward PE | n/a |
Analyst | Buy |
Ask | 83 |
Volume | 21,309,160 |
Avg. Volume (20D) | 8,650,110 |
Open | 90.11 |
Previous Close | 89.44 |
Day's Range | 78.80 - 91.28 |
52-Week Range | 22.89 - 91.45 |
Beta | undefined |
About TEM
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-iden...
Analyst Forecast
According to 11 analyst ratings, the average rating for TEM stock is "Buy." The 12-month stock price forecast is $58, which is a decrease of -29.17% from the latest price.
Why Price Moved
News

23 hours ago · businesswire.com
Tempus to Participate in the Morgan Stanley Technology, Media and Telecom ConferenceCHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley Technolo...